AIM: To evaluate the effect of interferon alpha (IFN-alpha) treatment on the liver histology in children with chronic hepatitis B and to evaluate the usefulness of various histological scoring systems of liver histology in this group of patients. METHODS: Fibrosis stage and inflammation grade were assessed according to Batts and Ludwig, Ishak et al., and METAVIR (only fibrosis stage) before and 12 mo after IFN-alpha treatment termination in 93 children aged 2-16 years with chronic hepatitis B. RESULTS: None of the three numerical scoring systems for liver fibrosis showed statistically significant differences in liver fibrosis, while evolution of inflammatory activity revealed statistically significant improvement in the whole group of children with chronic hepatitis B treated with IFN-alpha and in responders. Significantly positive correlations were found between fibrosis stage and inflammation grade in the respective scoring systems. CONCLUSION: Treatment with IFN-alpha did not improve histological fibrosis but decreased inflammatory activity in children with chronic hepatitis B. The three semiquantitative scoring systems seem to be comparable in the estimation of the inflammation grade and fibrosis stage in this group of children.
AIM: To evaluate the effect of interferon alpha (IFN-alpha) treatment on the liver histology in children with chronic hepatitis B and to evaluate the usefulness of various histological scoring systems of liver histology in this group of patients. METHODS:Fibrosis stage and inflammation grade were assessed according to Batts and Ludwig, Ishak et al., and METAVIR (only fibrosis stage) before and 12 mo after IFN-alpha treatment termination in 93 children aged 2-16 years with chronic hepatitis B. RESULTS: None of the three numerical scoring systems for liver fibrosis showed statistically significant differences in liver fibrosis, while evolution of inflammatory activity revealed statistically significant improvement in the whole group of children with chronic hepatitis B treated with IFN-alpha and in responders. Significantly positive correlations were found between fibrosis stage and inflammation grade in the respective scoring systems. CONCLUSION: Treatment with IFN-alpha did not improve histological fibrosis but decreased inflammatory activity in children with chronic hepatitis B. The three semiquantitative scoring systems seem to be comparable in the estimation of the inflammation grade and fibrosis stage in this group of children.
Authors: M L Shiffman; C M Hofmann; M J Contos; V A Luketic; A J Sanyal; R K Sterling; A Ferreira-Gonzalez; A S Mills; C Garret Journal: Gastroenterology Date: 1999-11 Impact factor: 22.682
Authors: K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween Journal: J Hepatol Date: 1995-06 Impact factor: 25.083
Authors: S J Williams; P I Craig; W G Cooksley; W A Bye; M Bilous; J M Grierson; B N Nightingale; L Burnett; W J Hensley; R G Batey Journal: Aust N Z J Med Date: 1990-02
Authors: T Fujisawa; H Komatsu; A Inui; T Sogo; Y Miyagawa; S Fujitsuka; I Sekine; T Kosugi; M Inui Journal: J Pediatr Gastroenterol Nutr Date: 2000-02 Impact factor: 2.839
Authors: F Capra; M Casaril; G B Gabrielli; P Tognella; A Rizzi; L Dolci; R Colombari; P Mezzelani; R Corrocher; G De Sandre Journal: J Hepatol Date: 1993-04 Impact factor: 25.083
Authors: R Sobesky; P Mathurin; F Charlotte; J Moussalli; M Olivi; M Vidaud; V Ratziu; P Opolon; T Poynard Journal: Gastroenterology Date: 1999-02 Impact factor: 22.682
Authors: Maria Elzbieta Sobaniec-Lotowska Sobaniec-Lotowska; Joanna Maria Lotowska; Dariusz Marek Lebensztejn Journal: World J Gastroenterol Date: 2007-06-07 Impact factor: 5.742